Light-responsive nanoparticle depot to control release of a small molecule angiogenesis inhibitor in the posterior segment of the eye

Therapies for macular degeneration and diabetic retinopathy require intravitreal injections every 4-8 weeks. Injections are uncomfortable, time-consuming, and carry risks of infection and retinal damage. However, drug delivery via noninvasive methods to the posterior segment of the eye has been a ma...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Control Release
Main Authors: Anh Nguyen Huu, Viet, Luo, Jing, Zhu, Jie, Zhu, Jing, Patel, Sherrina, Boone, Alexander, Mahmoud, Enas, McFearin, Cathryn, Olejniczak, Jason, de Gracia Lux, Caroline, Lux, Jacques, Fomina, Nadezda, Huynh, Michelle, Zhang, Kang, Almutairi, Adah
Formato: Artigo
Idioma:Inglês
Publicado em: 2015
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4384820/
https://ncbi.nlm.nih.gov/pubmed/25571784
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jconrel.2015.01.001
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados